Navigation Links
Ampio Pharmaceuticals to present at the International Society for Pharmaceutical Engineers (ISPE) 24th Annual Aseptic Processing Technology Conference on February 23rd, 2015
Date:2/20/2015

ENGLEWOOD, Colo., Jan. 20, 2015 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced that the company is scheduled to present on single use technology in manufacturing at the ISPE 24th Annual Aseptic Processing Technology Conference on Monday, February 23rd, 2015.  The presentation is scheduled for 9:25 AM Eastern Time at the Hilton Baltimore in Baltimore, MD.

Holli Cherevka, Ampio's Senior Director of Clinical Development and Operations, will provide an overview of the closed system single use product path used in the manufacture of Ampion™. 

About Ampio Pharmaceuticals:

Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company primarily focused on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. We are developing compounds that decrease inflammation by (i) inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; (ii) activating specific phosphatase or depletion of the available phosphate needed for the inflammation process; and (iii) decreasing vascular permeability.

Forward Looking Statements:

Ampio's statements in this press release that are not historical fact and that relate to future plans or events are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by use of words such as "believe," "expect," "plan," "anticipate," and similar expressions. These forward-looking statements include statements regarding Ampio's expectations with respect to the completion, timing and size of the registered direct offering, as well as risks associated with clinical trials, expected results, regulatory approvals, and changes in business conditions and similar events. The risks and uncertainties involved include those detailed from time to time in Ampio's filings with the Securities and Exchange Commission, including without limitation, under Ampio's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Ampio undertakes no obligation to revise or update these forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Contact:
April Ramirez
Operations Coordinator
Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Englewood, CO 80112
Direct: (720) 437-6524

Logo - http://photos.prnewswire.com/prnh/20120516/MM09116LOGO

 


'/>"/>
SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Ampio Pharmaceuticals Provides Clinical Updates
2. Ampio Pharmaceuticals to List on the NYSE MKT
3. Ampio Pharmaceuticals Issues Statement Regarding Misleading Blog
4. Dr. Helen Fisher to Speak at Astellas Presents Executive Womens Day at the Constellation SENIOR PLAYERS Championship
5. Pro Athletes Team Up to Champion Gout Awareness
6. Levine Leichtman Acquires Champion Manufacturing
7. Ampio Pharmaceuticals, Inc. Announces Positive Results for Ampion in Osteoarthritis of the Knee Clinical Trial
8. Astellas to Host Executive Womens Day at 2013 TOUR Championship by Coca-Cola
9. Ampio Pharmaceuticals, Inc. Announces $25 Million Financing
10. Ampio Pharmaceuticals, Inc. Announces Additional Positive Results for Ampion(TM) in Osteoarthritis of the Knee Clinical Trial
11. Ampio Pharmaceuticals subsidiary Luoxis Diagnostics announces positive summary data from study of traumatic brain injury patients and issuance of companys third US patent for its oxidation-reduction potential diagnostic platform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2020)... , ... January 23, 2020 , ... Please join American ... begins her term as the Society’s president for 2020. Dr. Dorbala is the director ... is an associate professor of radiology at Harvard. Over more than 20 years as ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... holds true for the complex architecture providing function to a person’s hand, wrist, ... – not just an orthopedic surgeon -- when anything goes wrong up or ...
(Date:1/22/2020)... ... January 22, 2020 , ... ... BX software to U.S. customers. A total redesign of their legacy software, the ... streamlined functionality and intuitive navigation, while maintaining the testing and training accuracy they ...
Breaking Medicine Technology:
(Date:1/24/2020)... ... January 24, 2020 , ... ... services company, announced today that it has completed its spin-off of HiPaaS, Inc ... technology cloud products, while Devcool Inc continues its growth and focuses on Healthcare ...
(Date:1/23/2020)... ... January 23, 2020 , ... The Mount Sinai Health System has ... firm Statista. , Mount Sinai was ranked No. 3 in the “Healthcare & Social” ... Health System is New York City’s largest academic medical system, including eight hospitals, a ...
(Date:1/23/2020)... ... 2020 , ... SignatureCare Emergency Center is set to expand to North Dallas ... Located in the heart of Lewisville, on 1596 W. Main St., Lewisville, TX 75067, ... support staff. , It will serve residents and businesses around Lewisville, TX, including ...
(Date:1/23/2020)... ... January 23, 2020 , ... Let’s face it; the ... out strongly. Old family issues, rivalries, and secrets were revisited. It’s easy to understand ... those coping with addiction and their families, the holidays posed additional stress for which ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... impairment, has announced the Best Memory Care Facilities in Pensacola, Florida. The guide ... and amenities. , According to the Alzheimer’s Association , 5.6 million ...
Breaking Medicine News(10 mins):